Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Higher levels of miR-203 may contribute to hair loss in alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

A 6-year-old girl with Turner syndrome also had psoriasis, alopecia areata, and trachyonychia.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Telemedicine is effective for diagnosing hair loss, especially in people with darker skin, during the pandemic.

Poor nutrition can lead to skin diseases in hospitalized patients and should be quickly identified and treated.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

The patient with Ankylosing Spondylitis had shoulder joint damage and bone changes.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Generalized pustular psoriasis patients often need strong medication and careful treatment due to flare-ups and complications.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

People with Collagen VI-related myopathies may often have hair loss and scalp issues.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Apremilast improved symptoms in patients with severe skin conditions.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Thermography matched the patient's pain levels in a shingles case and might help diagnose shingles without a rash.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.